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Abstract
Clinical examination is non-invasive, but has well-recognized limitations in
detecting compensated and uncompensated low flow states and their severity.
This paper describes the principles of near infra-red spectroscopy (NIRS) and the
basis for its proposed use, in hypovolaemic, cardiogenic and septic shock, for
assessing global and regional tissue oxygenation. The vascular occlusion test is
explained. Limitations of NIRS, current controversies, and what is necessary in
the future to make this technology a part of the initial and ongoing assessment of
a patient, are discussed as well. The ultimate goal of such techniques is to prevent
miss-assessment and inadequate resuscitation of patients, two major initiators in
the development of multisystem organ failure and death.
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Introduction
Oxygen delivery (DO2) is acutely reduced in all types of shock. Consequently,
tissue hypoxia occurs. Sustained tissue hypoxia is one of the most important
factors in the pathophysiology of organ dysfunction. (1) Maintenance of DO2 is
essential to preserve organ function, and sustained low DO2 is a path to organ
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failure and death. (2,3) Monitoring of global systemic and tissue oxygenation in
critically ill patients appears indispensable for their treatment. (4) Cardiogenic,
hypovolaemic and obstructive types of shock are characterized by decreased DO2,
but a preserved oxygen extraction ratio. In septic shock, tissue oxygen extraction
capability is altered so that the critical oxygen extraction ratio is typically
decreased. (2,3)
Clinical signs of tissue perfusion adequacy (capillary refill, mottling of the skin,
mental status, heart rate, pulse pressure, systemic blood pressure and urine
output) are not sufficiently sensitive indicators of tissue perfusion. (5-7)
Normalisation of these traditional clinical indices, after initial resuscitation, does
not exclude on-going inadequate tissue perfusion. (8) The search for a more
sensitive monitoring technology continues. (9) The ideal monitoring method
should perform as a sensitive, early index of altered state of oxygen delivery and
should also provide a goal for the treatment of low flow states, even before clinical
signs are evident.
Mixed venous oxygen saturation (SvO2) was traditionally used to estimate global
tissue oxygenation (oxygen delivery/oxygen consumption (VO2) ratio). But
catheterization of the pulmonary artery is costly, has inherent risks and its
usefulness remains under debate. (10-12) Not surprisingly, the monitoring of
central venous oxygen saturation (ScvO2) was suggested as a simpler and cheaper
assessment of global DO2 to VO2 ratio, (13) and was used successfully as a
hemodynamic goal in the treatment of patients with septic shock and severe
sepsis. (14) ScvO2 of 70% was subsequently included in the international guidelines
as a hemodynamic goal for the management of severe sepsis and septic shock. (15)
Although the relationship between systemic and peripheral circulation is not
always well defined, the assessment of peripheral perfusion during peripheral
cooling-induced vasoconstriction in healthy volunteers has shown that profound
changes in peripheral circulation can occur independently of systemic
haemodynamic parameters, such as blood pressure and cardiac output. (16)
Regional perfusion changes can occur significantly earlier than traditional global
indices. (17) The rationale of peripheral perfusion monitoring is based on a
concept that peripheral tissues are the first to reflect hypoperfusion during shock
and the last to reperfuse during resuscitation. (18) Examples of technologies which
may take advantage of regional changes and which may help identify these states,
include transcutaneous partial pressure of oxygen (pO2) and carbon dioxide
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partial pressure (pCO2), subcutaneous and interstitial pH, pCO2, and pO2
measurements, gastric and sublingual tonometry, and near-infrared absorption
spectroscopy (NIRS). (9)
Principles of NIRS
The concept of NIRS has already been available during the second half of 20th
century. (19) Visible light (450—700 nm) penetrates tissue only short distances
because of strong attenuation by various tissue components. However, in the near
infra-red (NIR) spectrum (700—1100 nm) photons are capable of deeper
penetration (several centimetres or more), even through bone. Metalloproteins
(haemoglobin, myoglobin and mitochondrial cytochrome oxidase) act as
chromophores and absorb NIR radiation differently based on their concentration
and interaction with oxygen. The Beer—Lambert law provides the physical and
mathematical basis for NIRS. This law states that light passing through a solution
of a coloured compound (chromophore) is absorbed by the compound resulting in
a reduction in the intensity of the emerging light. (20) A probe with a near infrared
light source is placed on the skin where it transilluminates tissues and detects
reflected light.
The basis for the use of NIRS to monitor changes in haemoglobin (Hb) and
oxyhaemoglobin (HbO2), and to monitor states of tissue oxygenation, lies in the
tissue compartmentalisation of blood volume, which in most organ systems is
believed to be proportioned among the arteriolar, capillary, and venular
compartments in a ratio of 10:20:70% respectively. (21,22) Consequently, the
majority of the NIRS signal, reflects the venous or post-extraction compartment
of any particular tissue. This phenomenon provides valuable information on tissue
oxygen consumption or extraction in much the same way as mixed venous
haemoglobin oximetry is used from the pulmonary artery catheter. The NIR value
of haemoglobin oxygen saturation from the tissue (StO2) thus represents spatially
integrated information from arterioles, capillaries, and venules, which are
normally weighted towards the venous compartment. Larger vessels (>1mm) are
assumed to be excluded from StO2 determination. (23)
Clinical and technical considerations in NIRS
measurements
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Microcirculatory perfusion and tissue oxygen utilization are affected by sepsis and
shock. (24,25) These derangements can be studied non-invasively using NIRS, a
technique that is able to determine the oxygenation status of tissue haemoglobin.
Decreased StO2 reflects the presence of hypoperfusion and has been used
clinically to guide resuscitation during hypovolaemic shock. (26) Thus,
determination of regional StO2 might provide an early warning index of global
hypoperfusion prior to significant alterations in vital signs or critical DO2 and
help the clinician to verify that oxygen delivery to the tissue had been restored to
a desired level.
Measurements of StO2 are noninvasive, continuous, bedside and simple. NIRS
equipment is becoming light and easy to handle – all these characteristics make
this method fit for emergency and critical care use.
The anatomical advantages of the thenar eminence are: the easy bedside
approach; the thenar eminence can be easily subjected to the vascular occlusion
test; has relatively thin skin and fat tissue over the muscle; and fibrous strands in
its subcutaneous tissue limit oedema formation. All these characteristics make the
thenar eminence the best possible setting for StO2 measurements, even in
critically ill or obese patients.
In a human validation study, a significant correlation between NIRS measured
StO2 and venous oxygen saturation (r=0.92, p < 0.05) was reported, where the
venous effluent was obtained from a deep forearm vein that drained the
exercising muscle. (27) StO2 was minimally affected by skin blood flow. Changes of
limb perfusion affect StO2: skeletal muscle StO2 decreases during norepinephrine
and increases during nitroprusside infusion.
Choosing the right probe is crucial. The distance between the source of NIR light
and the receiver of reflected light defines the depth and the volume of the
transilluminated tissues under the probe. If one uses a 15 mm probe, penetration
is only 7,5 mm, thus the measurements will be importantly influenced by the skin
and subcutaneous tissue oxygenation and will not represent skeletal muscle
oxygenation. At our department we use deep penetrating probes (25 mm probes)
and probes with filtering of superficial structures. (28)
The discriminatory power and predictive ability of StO2 can be improved by
measuring the response to an ischaemic challenge. The vascular occlusion test
(VOT) is a provocative test in which StO2 is measured at a peripheral site (such as
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the thenar eminence) whilst a transient rapid vascular occlusion is performed
(above elbow cuff inflation to 260 mmHg) for either a defined time interval or until
a pre-defined StO2 value is reached. During the vascular occlusion test, several
StO2 parameters can be studied: average StO2 before arterial cuffing/occlusion;
StO2 downslope during cuffing- the deoxygenation rate (∆down StO2)/sec); StO2
upslope (∆up StO2)/sec); hyperaemia (overshoot of StO2 above baseline) (figure 1).
The deoxygenation rate is a surrogate for tissue oxygen consumption. (25) StO2
and arterial oxygen saturation measured by transcutaneous pulse oxymetry can
be used to calculate fractional tissue oxygen extraction according to the formula:
(SaO2 – rStO2)/SaO2. (29)
NIRS for evaluation of skeletal muscle tissue
oxygenation in hypovolaemic shock
During hypovolaemic shock, blood flow is diverted from less important tissues to
vital organs leading to decreased blood flow in muscles. Activation of the
sympathetic nervous system should decrease thenar muscle blood flow, with
increased oxygen extraction and decreased tissue haemoglobin content. (18,30) In
this setting, NIRS may thus act as a sensor of the vascular response to
hypovolaemia. This hypothesis was tested in trauma patients and the
perioperative period.
Already in the late 1990s, at the University of Texas Houston Medical School, a
team of surgical intensivists collaborated with bioengineers and health
information experts to improve traumatic shock resuscitation. They tested the
utility of various monitors in this process of care. One such monitor was StO2.
Throughout resuscitation, skeletal muscle StO2 appeared to be quite responsive to
changes in systemic DO2. SvO2 derived from the pulmonary artery (PA) catheter
showed only a small rise from roughly 70 to 78% during the resuscitation process,
changes in StO2 showed a strong correlation with changes in DO2, base deficit,
and lactate (r = 0.95 vs. 0.83 vs. 0.82, respectively) but only modest correlation
with SvO2 (r = 0.55). (26)
Furthermore, trauma patients who develop multiorgan dysfunction (MODS) or
die, have a lower StO2 within 1 hour of admission, and StO2 is a stronger predictor
of MODS or death than other diagnostic modalities. (31,32) A low StO2 within 1
hour of admission identifies trauma patients who will require blood transfusion
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within the next 24 hours. (33)
An area of central interest in anaesthesia is the ability of NIRS measurements in
the thenar muscle to detect blood loss. Data are conflicting. A 500-ml blood loss at
blood donation in awake volunteers did not lead to changes in StO2. (34) A possible
explanation could be that tissue haemoglobin and oxygenation at the thenar
eminence are not affected by blood loss within the capacity of the compensatory
mechanisms of hypovolaemia. However, StO2 during the perioperative period in
cardiac surgery is lower in patients who develop certain postoperative
complications. (35)
NIRS for evaluation of skeletal muscle tissue
oxygenation in cardiogenic shock
Measurement of mixed venous oxygen saturation (SvO2) from the pulmonary
artery is used for calculations of oxygen consumption and has been advocated as
an indirect index of tissue oxygenation and prognostic predictor in critically ill
patients. (36-39) We studied skeletal muscle StO2 in severe left heart failure with
or without additional severe sepsis, and compared it with SvO2. (40) The
hypothesis was that skeletal muscle StO2 could estimate SvO2 in patients with
severe left heart failure and preserved oxygen extraction capability (without
severe sepsis/septic shock).
In patients with severe left heart failure (n = 24) StO2 was lower than in healthy
volunteers (58 ± 13% and 84 ± 4%, respectively; p < 0.001). There was a good
correlation between StO2 and SvO2 (figure 2), and between SvO2 and plasma
lactate (r = 0.689, p = 0.002, r = -0.522, p = 0.009, respectively). StO2 and SvO2
tracked well with each other over time, although StO2 overestimated SvO2 with a
bias of – 2.3% and a precision 4.6%.
The result confirmed the hypothesis that skeletal muscle StO2 values in patients
with severe left heart failure could be used for fast non-invasive SvO2 estimation;
and the trend of StO2 may be substituted for the trend of SvO2. StO2
overestimated SvO2 (bias -2.5%). (40) Overestimation may be due to the NIRS
method, which does not discriminate between compartments. It provides a global
assessment of oxygenation in all vascular compartments (arterial, venous and
capillary) in the sample volume of underlying tissue.
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Our data in patients with severe heart failure/ cardiogenic shock without severe
sepsis/ septic shock are supported by previous work from Boekstegers et al. who
measured the oxygen partial pressure distribution in the biceps muscle. (41) They
found low peripheral oxygen availability in cardiogenic shock compared to sepsis.
In cardiogenic shock, skeletal muscle oxygen partial pressure correlated with
systemic oxygen delivery (r=0.59, p < 0.001) and systemic vascular resistance
(r=0.74, p < 0.001). In a recently published study in patients experiencing
cardiogenic shock, significant correlations between StO2 values and cardiac index
(CI) (Spearman r=0.81; p < .0001), systemic vascular resistance index (r=-0.45; p <
.0001), and mean arterial pressure (r=0.58; p < .0001) were found. Linear
regression analysis revealed that CI could be calculated using the following
equation: CI = StO2/24.0. (42)
NIRS for evaluation of skeletal muscle tissue
oxygenation in septic shock
In sepsis, StO2 values can be at the higher end of the normal spectrum (40,43,44)
or markedly low. (45,46) In early stage septic shock, low StO2 values (i.e., StO2 <
75%), when measured on the thenar eminence, specifically predict extremely low
ScvO2 values and higher mortality. (46,47)
Our research group confirmed De Blasi group’s findings (48) that thenar muscle
tissue deoxygenation during stagnant ischaemia at admission and after
haemodynamic stabilisation is significantly slower in septic shock patients
compared to severe sepsis, localized infection and healthy controls. (44) The rate
of StO2 decrease correlated tightly with severity of septic shock (Sequential Organ
Failure Assessment score) and weakly with norepinephrine requirement, plasma
lactate and C-reactive protein concentrations. The muscle tissue deoxygenation
rate increased with improvement of sepsis in the septic shock and severe sepsis
group. (44) These results are in accordance with those reported in a baboon septic
shock model. (49) These data were interpreted as being consistent with the
presence of a defect in the ability of the enzyme to accept electrons from oxygen
or a limitation in the availability of the reducing equivalent. Similar results were
reported in the dog gracilis muscle preparation after treating the animals with
endotoxin. (50)
This local oxygen consumption limitation may be due to two different but
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cumulative mechanisms: first – a local dependency on low flow or inadequate flow
conditions (46) or second – a low oxygen extraction due to mitochondrial
dysfunction and/or alteration of oxygen diffusion (interstitial oedema). (25,46,48)
Although the mechanism involved in sepsis resuscitation is not yet fully
understood, it is clear that the persistence of impaired peripheral perfusion is
associated with worse patient outcomes. (51)
In the previously described study of patients with severe left heart failure, with or
without additional severe sepsis/septic shock (40), we hypothesized a
disagreement between StO2 and SvO2 in the group of patients with sepsis,
because in patients with decreased oxygen extraction capability (with severe
sepsis/septic shock), blood flowing through upper limb muscles could importantly
contribute to higher venous oxygen saturation in the superior vena cava. The
results confirmed the hypothesis (figure 2). StO2 correlated neither with SvO2 nor
with serum lactate.
The high StO2 / low SvO2 seen in severe sepsis and septic shock, suggest blood
flow redistribution. StO2 probably correlates with ScvO2 which is measured in the
mixture of blood from head and both arms. (52) In healthy resting individuals
ScvO2 is slightly lower than SvO2. (53) This relationship changes in periods of
cardiovascular instability. Scheinman and co-workers performed the earliest
comparison of ScvO2 and SvO2 in both haemodynamically stable and shocked
patients . (54) In stable patients, ScvO2 was similar to SvO2. In patients with a
failing heart, ScvO2 was slightly higher than SvO2 and in shock patients the
difference between SvO2 to ScvO2 was even more expressed (47.5% ± 15.11% vs.
58.0% ± 13.05%, respectively, p < 0.001). Lee and co-workers described similar
findings. (55) Other more detailed studies in mixed groups of critically-ill patients
designed to test if the ScvO2 measurements could substitute the SvO2 showed
problematically large confidence limits (56) and poor correlation between the two
values. (57)
The hypothesis that the slower skeletal muscle StO2 deoxygenation rate (more
disturbed tissue oxygen extraction) is proportional to the ScvO2-SvO2 difference
in patients with severe heart failure with additional sepsis/septic shock, was
confirmed by our more recent study. (58) We showed that these patients had a
clinically considerable ScvO2-SvO2 discrepancy. Monitoring ScvO2 is a simpler
and cheaper assessment of global DO2 to oxygen consumption ratio, but its use as
a treatment goal in patients with severe heart failure, with additional sepsis/septic
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shock, is questionable. Higher levels of ScvO2 in patients in the latter stages of
septic shock were found in the non-survivors. (59) These findings raise concerns
about high levels of ScvO2 in patients with septic shock. Consequently, ScvO2 or
probably StO2, as a treatment goal, provides a false favourable impression of
adequate body perfusion. Future studies that implement NIRS into treatment
algorithms are ongoing.
Summary
The present review provides a foundation for understanding the potential value
and limitations of NIRS as a tool in the assessment of patients with different types
of shock. Despite continuous controversies, skeletal muscle NIRS clearly takes
monitoring from a global to a local level, from invasive to non-invasive, and closer
to the entrance to the hospital.
In low cardiac output states, with preserved oxygen extraction ratio (cardiogenic,
hypovolaemic types of shock), StO2 measurements correlate well with invasive
global indexes of oxygen delivery and consumption. In hypovolaemic shock and in
the perioperative period, StO2 is a good prognostic tool. In septic shock the
oxygen extraction capability is altered, and StO2 correlates better with ScvO2 than
with SvO2, however, correlation coefficients are relatively low. In patients with
severe sepsis and severe heart failure StO2 did not estimate SvO2, but, in the end,
data suggest that in patients in early phase of septic shock low StO2 predicts low
ScvO2 and higher mortality.
Dynamic StO2 monitoring, with vascular occlusion test, is a promising technique
with the potential of insight into microvascular and mitochondrial function. Used
in conjunction with global measures of oxygen delivery, it could provide an
integrated approach to haemodynamic resuscitation in different types and phases
of shock.
Figure 1. Vascular occlusion test: An original thenar saturation from the tissue
(StO2) recording after arterial upper arm cuffing, and cuffing release (upper arm
ischaemia reperfusion test). During the upper arm ischaemia reperfusion test,
several StO2 parameters can be studied: average StO2 before arterial
cuffing/occlusion; StO2 downslope during cuffing-the deoxygenation rate (∆down
StO2)/sec); StO2 upslope (∆up StO2)/sec); hyperaemia (overshoot of StO2 above
baseline). Reproduced from Mozina and Podbregar. (25)
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Figure 2. Correlation between skeletal muscle saturation from tissue (StO2) and
mixed venous oxygen saturation (SvO2). Group A includes patients with severe left
heart failure without severe sepsis/septic shock, and group B includes patients
with primary heart disease and additional severe sepsis/septic shock. A
statistically significant correlation was found in group A (r = 0.689, p = 0.002) but
not in group B (r = -0.091, p = 0.60). StO2, tissue oxygenation; SvO2, mixed venous
oxygen saturation. Modified from Podbregar and Mozina. (40)
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